Clinical trials: Dual Anti-Platelet Therapy
- Condition Dual Anti-Platelet Therapy
- Funder type Industry (pharma, biotech, devices)
- Has posted results yes
Coronary Artery Disease
COBRA PZF™ Coronary Stent for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term DAPT
This is a prospective, multi-center, non-randomized, single arm clinical trial that will be conducted at up to 40 sites in the United States and Outside United States (OUS).
- Trial name
- NCT01925794
- Testing
- COBRA PzF
- Where
- 35 sites in United States, France and 5 more
- Volunteers
- 296 people
- Sponsor
- CeloNova BioSciences, Inc.
Coronary Artery Disease
CYPRESS - CYPHER for Evaluating Sustained Safety
CYPRESS: A Prospective,Randomized,Multi-Center,Double-Blind Trial to Assess the Effectiveness and Safety of Different Durations of Dual Anti-Platelet Therapy (DAPT) in Subjects Undergoing Percutaneous Coronary Intervention with…
- Trial name
- NCT00954707
- Testing
- Clopidogrel & Aspirin, Prasugrel & Aspirin
- Where
- United States
- Volunteers
- 2,509 people
- Sponsor
- Cordis US Corp.